Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAVICTI vs NaPBA in Treatment-Naïve Urea Cycle Disorders
NCT03335488Phase 4Completed
- Sponsor
- Amgen
- Start
- Feb 2018
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of glycerol phenylbutyrate in urea cycle disorders (UCD), sponsored by Amgen. Started Feb 2018; status: completed.
02
Drugs
glycerol phenylbutyrate
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT03335488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335488.